Cannabis Law Report

DECEMBER 28, 2021

The users of CBD products claim to have seen improvement in different medical conditions, including depression, chronic pain, insomnia, epilepsy, anxiety, etc., But things have changed after FDA eased out regulations in 2015 to carry out CBD trials. after its consumption. Myth # 4: CBD Benefits Have No Scientific Proof.

CBD 52

CBD Clinical Trials Consumption Chronic Pain 52

MMJ Recs

APRIL 20, 2022

It wasn’t until 2014 and 2015 that the state began to see action in terms of accessing and using medical marijuana for health conditions. In order to get a medical card in Louisiana, you have to be resident of the state who has one of the qualifying conditions.

Patients 52

Patients Marijuana Access Dispensary 52

CannaTech

JANUARY 16, 2019

Medical cannabis continued to pop up across the region year after year: imports in Brazil began in 2014, trials started in Chile in 2014, regulations were implemented in Colombia and Jamaica in 2015, the same followed in the Cayman Islands and parts of Argentina in 2016, Paraguay in 2017, and the list carries on from 2018 to date.

Access 89

Access Patients Pharmaceutical Education 89

Cannabis Law Report

OCTOBER 20, 2019

sat on the Denver County Court bench 2000-2015. For example, there is a growing body of evidence that marijuana is working for chronic pain. Whether or not the pharmaceutical industry can produce a substance they can call a drug that would be approved for a pain indication remains the question,” [xiv]. Kleignen, 2015.

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Otherside Farms

FEBRUARY 14, 2019

billion by 2020; the World Anti-Doping Agency eliminated the CBD from its list of banned substances; The Food and Drug Administration (FDA) for the first time approved a drug for epilepsy that contained CBD oil, prompting the US Drug Enforcement Administration to change its position about the CBD. What is CBD?

CBD 65

CBD Legalization Hemp Chronic Pain 65

Veriheal

OCTOBER 5, 2020

The qualifying conditions for medical cannabis has been established in the bill as follows: Amyotrophic Lateral Sclerosis (ALS), Cachexia, Cancer, Chronic Pain, Crohn’s Disease, Epilepsy, Glaucoma, HIV/Aids, Lupus, Multiple Sclerosis, Nausea, Persistent Muscle Spasms, Post-traumatic Stress Disorder (PTSD), Rheumatoid Arthritis. .

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Cannabis Law Report

MAY 6, 2022

Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products. Examples of sellers’ language the FDA views as illegal are the following: “Our line of …CBD oil … is great for insomnia, epilepsy, MS, schizophrenia, and chronic pain.”.

THC 52

THC CBD Media Food 52

Cannabis Law Report

MAY 16, 2019

It is claimed that medicinal cannabis can decrease anxiety, provide relief from chronic pain, alleviate nausea, assist symptoms of spasticity in people with multiple sclerosis and treat epilepsy. The report raised a number of structural issues and the Bill finally lapsed at prorogation on 17 April 2016.

Medicine 45

Medicine Chronic Pain Access Patients 45

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Cancer pain. Neuropathic pain. 2015 ; Kaiser 2011 ; Mortensen et al. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

SEPTEMBER 28, 2019

A symposium in Limerick has heard that the medical cannabis access programme here is too restrictive and needs to be extended to include people who suffer with chronic pain. The text sanctions the total failure of repression policies, citing the now famous 2015 report of the Italian National Anti-Mafia Directorate.

Epilepsy 40

Epilepsy Chronic Pain Medicine Pharmaceutical 40

Green Relief

JANUARY 18, 2018

Due to its non-psychoactive healing properties, Cannabidiol (CBD) has become a very popular option for patients seeking a natural alternative to treat conditions such as chronic pain, anxiety, epilepsy, and more. CBD VS. FULL SPECTRUM CBD: WHICH IS MORE EFFECTIVE?

CBD 56

CBD Cannabinoids Chronic Pain Epilepsy 56

Cannabis Law Report

SEPTEMBER 23, 2019

7 While the lifetime use remains relatively stable for this cohort, from 2015-2017, past year and past month use increased 2.7% In 2015, Whiting, et al, performed a meta-analysis and systematic review of research on the medical use of cannabis. Cannabinoids have been assessed for chronic pain management.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Green Relief

JANUARY 18, 2018

Due to its non-psychoactive healing properties, Cannabidiol (CBD) has become a very popular option for patients seeking a natural alternative to treat conditions such as chronic pain, anxiety, epilepsy, and more. CBD VS. FULL SPECTRUM CBD: WHICH IS MORE EFFECTIVE?

Cannabinoids 40

Cannabinoids Chronic Pain CBD Conditions 40

Kind Meds (Cannabis Education Blog)

JANUARY 7, 2019

The details are based on a study conducted in Israel from 2015 through October 2017. Participants were all over 65 years of age and amidst treatment for pain with medical cannabis via product from the largest medical cannabis supplier in that country. Alternative Treatments for Pain, Physical and Mental Illness. Chronic Pain.

Marijuana 83

Marijuana Treatment Chronic Pain Strains 83

The Cannigma

MARCH 12, 2021

So, obviously, the person who’s taking cannabis for Parkinson’s, or epilepsy, or cancer is a very different type of patient than the person who’s taking it for wellness as say, a supplement, which does overlap with many rec users. So, now fast forward to about 2015 or so, and my brother is diagnosed with multiple sclerosis.

Legalization 128

Legalization Patients Education Dispensary 128

Medical Cannabis Seedbank

AUGUST 6, 2018

Synthesized CBD, and carried out the first study on its effects on epilepsy patients over 30 years ago. Cancer patients and those with chronic pain have prescription access to the substance. The International Cannabis and Cannabinoids Institute (ICCI) is located in Prague and opened at the end of 2015.

Research and Development 61

Research and Development Cultivation Chronic Pain Cannabis 61

Greencamp

DECEMBER 4, 2018

Chronic Pain. Fuss J, Steinle J, Bindila L, Auer MK, Kirchherr H, Lutz B, Gass P; A runner’s high depends on cannabinoid receptors in mice; 2015; 112(42). According to his research, clinical ECS deficiency can have a negative influence on many conditions and diseases, including: Migraines. Irritable Bowel Syndrome (IBS).

Cannabinoids 107

Cannabinoids Research and Development Conditions THC 107

Green Relief

MAY 13, 2018

It is the most commonly identified cause of epilepsy among adults. According to a 2015 study in Neurotherapeutics , “Upregulation of CB2 with no changes in CB1 have been found in TBI.”. Triggered by concussions from car accidents, falls, violent contact sports, explosives or by gunshot and stab wounds, TBI affects 1.7

THC 64

THC CBD Cannabinoids Research and Development 64

Veriheal

MAY 11, 2023

In 2015, Texas passed the Compassionate Use Act, which allowed patients with intractable epilepsy to access low-THC cannabis oil containing no more than 0.5% THC and at least 10% CBD.

Programs 89

Programs Chronic Pain Conditions THC 89

SpeedWeed

APRIL 29, 2021

Under HB 1535 , the Texas medical cannabis expansion would cover chronic pain, all forms of cancer, and post-traumatic stress disorder. The bill was drafted by Representative Stephanie Klick, a Republican and the same person who wrote the initial 2015 medical cannabis bill in Texas. .

Programs 52

Programs Chronic Pain Access Patients 52

StrainConnect

FEBRUARY 8, 2019

From cancer(11) to epilepsy(12), there seems to be very little that cannabis cannot help with. A 2015 Israeli study found that full-spectrum CBD oil is effective at much lower doses and has a wider therapeutic window than a CBD isolate(17). Endocannabinoids and epilepsy - Science Direct. 2015, Feb.). 2015, Jan.).

Hemp 57

Hemp CBD Cannabinoids Sativa 57

Cannabis Law Report

JANUARY 9, 2019

Various patients who live in Texas are hopeful that the bills will pass, if only to allow them easier access to a drug treatment option that has proven very effective for issues from anxiety to chronic pain. That’s significant because in June, the federal government approved a CBD drug for epilepsy for the first time.

Treatment 40

Treatment Legislation Patients Epilepsy 40